Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – Intraperitoneal chemotherapy may significantly improve long-term survival in ovarian cancer patients, a new study found. Data from 876 patients followed for a median…
NEW YORK (Reuters Health) – The risk of arterial thromboembollic events related to bevacizumab treatment of colorectal cancer (CRC) in older patients is moderate in general practice, and…
NEW YORK (Reuters Health) – In cancer patients with a central venous catheter (CVC), the occurrence of a related infection or thrombosis can often be resolved while the…
NEW YORK (Reuters Health) – The rate of incidental thyroid cancer detected among patients who undergo thyroidectomy for apparently benign disease is unexpectedly high, especially in cases of…
NEW YORK (Reuters Health) – Patients with acute myeloid leukemia (AML) who do not receive a stem-cell transplant during first remission and then relapse have a fair chance of…
NEW YORK (Reuters Health) – Anticoagulant use may be a predictor of overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel, retrospective data suggest. The…
NEW YORK (Reuters Health) – Transplantation of hematopoietic cells from a donor with a single matched HLA haplotype, combined with post-transplant cyclophosphamide, may be a good alternative when…
NEW YORK (Reuters Health) – Patients with follicular non-Hodgkin lymphoma that has transformed into aggressive-histology lymphoma do better when treated with high-dose chemotherapy followed by autologous stem-cell transplantation…
NEW YORK (Reuters Health) – Reducing exposure to alkylating agents in patients with Hodgkin lymphoma is key to reducing the risk of developing therapy-related acute myeloid leukemia or…
NEW YORK (Reuters Health) – Agents that target the mTOR axis, which have become particularly important in the treatment of advanced renal cell carcinoma (RCC), have significant adverse…
